Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Chỉ hiển thị Multimedia
Linerixibat quells cholestatic itch in PBC, enabling better sleep
23 May 2025
bởiJairia Dela Cruz
The ileal bile acid transporter inhibitor linerixibat provides rapid and substantial relief from cholestatic pruritus, in turn reducing associated sleep disturbances, in patients with primary biliary cholangitis (PBC), as shown in the global, phase III GLISTEN trial.
Linerixibat quells cholestatic itch in PBC, enabling better sleep
23 May 2025
Seladelpar benefit in PBC sustained at 3 years
22 May 2025
bởiAudrey Abella
The selective PPARδ* agonist seladelpar continues to demonstrate benefit in patients with primary biliary cholangitis (PBC) in the long-term pooled analysis from the ongoing open-label phase III ASSURE trial.
